Call (704)-333-7376 Are You a New Patient/Provider?
Click Here Are You a Current Patient/Provider?

Archive for category: Cancer news

You are here: / / Cancer news
At this time, patients with cancer may be offered vaccination against COVID-19

COVID-19 Vaccines and People with Cancer

COVID-19 is now the leading cause of death in the United States, with more daily deaths than those caused by heart disease, typically the number one killer. Over 540,000 Americans have died from the…

Exciting SGRT Clinical Trial Underway

One of the major challenges involving lung cancer is early detection and treatment. Levine Cancer Institute’s Division of Radiation Oncology (LCI), including many of SERO’s physicians, is proud to…
CURE logo, a print magazine and web resource, provides cancer updates, research, and education.

CURE Article Recap feat. John Heinzerling, MD

John H. Heinzerling, MDEveryone desires a cure for cancer; however, people need to understand that every cancerous process is different. This means that every type of cancer will require its own individual…
Dr. Chris Corso (SER0) hosted Senator Burr’s staff on behalf of ASTRO at radiation therapy center in Charlotte, NC

Dr. Corso at SERO Hosts Senator Burr’s Health Policy Director

Without a doubt, there have been numerous advances in the field of cancer diagnostics and treatment over the past few decades. These advancements have given hope to individuals and families suffering…

Men’s Health Week: June 11-17

Did you every June brings National Men’s Health Week?  We would like to take this opportunity to provide several great ways men can pay attention to their health and ensure they are taking care of…

May is Cancer Research Month

May is cancer research month, and there are some truly fascinating and groundbreaking cancer studies happening all over the world. The following are several brief summaries of recent studies and research…

Dr. Heinzerling Presents His Research at the OncLive State of the Science Summit

Dr. Heinzerling Presents His Research at the OncLive State of the Science Summit Written by: SERO StaffDr. Heinzerling presented on the topic of Advanced Non-Small Cell Lung Cancer at the OncLive…

Christopher Corso, MD, Ph.D Receives 2017 Basic/Translational Science Abstract Award

Christopher Corso, MD, Ph.D Receives 2017 Basic/Translational Science Abstract Award Written by: SERO StaffThe Basic/Translational Science Abstract Award recognizes the lead authors of 12 top-rated…

Scientists Use Deadly Virus to Fight Brain Tumors

Scientists looking for new treatments for patients with brain tumors, including those caused by metastatic melanoma, have turned to an unlikely source: a deadly tropical virus. The virus, called Lassa, causes a deadly hemorrhagic fever endemic to West Africa. A team of cancer scientists from Yale and Harvard are altering part of the virus's genetic code, combining it with a different virus, and injecting it into the human brain where they hope it can be used to find and destroy cancer cells.

New Cancer Drug Binimetinib Shows Success in Late Stage Trial

On December 16, Array BioPharma announced its new cancer drug, binimetinib, showed success in stage 3 clinical trials. According to the drug company, binimetinib may be used to treat people with advanced NRAS-mutant melanoma, a particularly deadly form of skin cancer. The trial showed that the drug extended the time it takes for cancer to grow and spread.